Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 250

    1.

    Meta-analysis: pharmacologic treatment of obesity.

    Li Z, Maglione M, Tu W, Mojica W, Arterburn D, Shugarman LR, Hilton L, Suttorp M, Solomon V, Shekelle PG, Morton SC.

    Ann Intern Med. 2005 Apr 5;142(7):532-46.PMID: 15809465 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Long-term pharmacotherapy for obesity and overweight.

    Padwal R, Li SK, Lau DC.

    Cochrane Database Syst Rev. 2004;(3):CD004094. Review.PMID: 15266516 [PubMed - indexed for MEDLINE]Related articles

    3.

    Long-term pharmacotherapy for obesity and overweight.

    Padwal R, Li SK, Lau DC.

    Cochrane Database Syst Rev. 2003;(4):CD004094. Review. Update in: Cochrane Database Syst Rev. 2004;(3):CD004094. PMID: 14584004 [PubMed - indexed for MEDLINE]Related articles

    4.

    Pharmacotherapy for weight loss in adults with type 2 diabetes mellitus.

    Norris SL, Zhang X, Avenell A, Gregg E, Schmid CH, Lau J.

    Cochrane Database Syst Rev. 2005 Jan 25;(1):CD004096. Review.PMID: 15674929 [PubMed - indexed for MEDLINE]Related articles

    5.

    Pharmacotherapy for obesity.

    Ioannides-Demos LL, Proietto J, McNeil JJ.

    Drugs. 2005;65(10):1391-418. Review.PMID: 15977970 [PubMed - indexed for MEDLINE]Related articles

    6.

    [Pharmacological therapy of obesity]

    Pagotto U, Vanuzzo D, Vicennati V, Pasquali R.

    G Ital Cardiol (Rome). 2008 Apr;9(4 Suppl 1):83S-93S. Italian. PMID: 18773755 [PubMed - indexed for MEDLINE]Related articles

    7.

    Efficacy of pharmacotherapy for weight loss in adults with type 2 diabetes mellitus: a meta-analysis.

    Norris SL, Zhang X, Avenell A, Gregg E, Schmid CH, Kim C, Lau J.

    Arch Intern Med. 2004 Jul 12;164(13):1395-404. Review.PMID: 15249348 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Long-term effects of weight-reducing drugs in hypertensive patients.

    Siebenhofer A, Horvath K, Jeitler K, Berghold A, Stich AK, Matyas E, Pignitter N, Siering U.

    Cochrane Database Syst Rev. 2009 Jul 8;(3):CD007654. Review.PMID: 19588440 [PubMed - indexed for MEDLINE]Related articles

    9.

    Long-term pharmacotherapy for overweight and obesity: a systematic review and meta-analysis of randomized controlled trials.

    Padwal R, Li SK, Lau DC.

    Int J Obes Relat Metab Disord. 2003 Dec;27(12):1437-46. Review.PMID: 12975638 [PubMed - indexed for MEDLINE]Related articles

    10.

    Head-to-head studies evaluating efficacy of pharmaco-therapy for obesity: a systematic review and meta-analysis.

    Neovius M, Johansson K, Rössner S.

    Obes Rev. 2008 Sep;9(5):420-7. Epub 2008 Jan 15. Review.PMID: 18208467 [PubMed - indexed for MEDLINE]Related articles

    11.

    Weight management and current options in pharmacotherapy: orlistat and sibutramine.

    Leung WY, Thomas GN, Chan JC, Tomlinson B.

    Clin Ther. 2003 Jan;25(1):58-80. Review.PMID: 12637112 [PubMed - indexed for MEDLINE]Related articles

    12.

    Weight-loss outcomes: a systematic review and meta-analysis of weight-loss clinical trials with a minimum 1-year follow-up.

    Franz MJ, VanWormer JJ, Crain AL, Boucher JL, Histon T, Caplan W, Bowman JD, Pronk NP.

    J Am Diet Assoc. 2007 Oct;107(10):1755-67. Review.PMID: 17904936 [PubMed - indexed for MEDLINE]Related articles

    13.

    Clinical review: treatment of pediatric obesity: a systematic review and meta-analysis of randomized trials.

    McGovern L, Johnson JN, Paulo R, Hettinger A, Singhal V, Kamath C, Erwin PJ, Montori VM.

    J Clin Endocrinol Metab. 2008 Dec;93(12):4600-5. Epub 2008 Sep 9. Review.PMID: 18782881 [PubMed - indexed for MEDLINE]Related articles

    14.

    Efficacy and safety of ephedra and ephedrine for weight loss and athletic performance: a meta-analysis.

    Shekelle PG, Hardy ML, Morton SC, Maglione M, Mojica WA, Suttorp MJ, Rhodes SL, Jungvig L, Gagné J.

    JAMA. 2003 Mar 26;289(12):1537-45. Epub 2003 Mar 10.PMID: 12672771 [PubMed - indexed for MEDLINE]Related articles

    15.

    NPY5R antagonism does not augment the weight loss efficacy of orlistat or sibutramine.

    Erondu N, Addy C, Lu K, Mallick M, Musser B, Gantz I, Proietto J, Astrup A, Toubro S, Rissannen AM, Tonstad S, Haynes WG, Gottesdiener KM, Kaufman KD, Amatruda JM, Heymsfield SB.

    Obesity (Silver Spring). 2007 Aug;15(8):2027-42.PMID: 17712121 [PubMed - indexed for MEDLINE]Related articles

    16.

    Orlistat and sibutramine beyond weight loss.

    Mannucci E, Dicembrini I, Rotella F, Rotella CM.

    Nutr Metab Cardiovasc Dis. 2008 Jun;18(5):342-8. Epub 2007 Oct 24.PMID: 17928208 [PubMed - indexed for MEDLINE]Related articles

    17.

    Long term pharmacotherapy for obesity and overweight: updated meta-analysis.

    Rucker D, Padwal R, Li SK, Curioni C, Lau DC.

    BMJ. 2007 Dec 8;335(7631):1194-9. Epub 2007 Nov 15. Erratum in: BMJ. 2007 Nov 24;335(7629). doi: 10.1136/bmj.39406.519132.AD. PMID: 18006966 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    What interventions should we add to weight reducing diets in adults with obesity? A systematic review of randomized controlled trials of adding drug therapy, exercise, behaviour therapy or combinations of these interventions.

    Avenell A, Brown TJ, McGee MA, Campbell MK, Grant AM, Broom J, Jung RT, Smith WC.

    J Hum Nutr Diet. 2004 Aug;17(4):293-316. Review.PMID: 15250841 [PubMed - indexed for MEDLINE]Related articles

    20.

    Pharmacologic options for the treatment of obesity.

    Campbell ML, Mathys ML.

    Am J Health Syst Pharm. 2001 Jul 15;58(14):1301-8. Review.PMID: 11471477 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data